In silico repurposed drugs against monkeypox virus
Lam, H. Y. I.; Guan, J. S.; Mu, Y.
10.1101/2022.07.17.500371 bioRxivShow abstract
Monkeypox is an emerging epidemic of concern. The disease is caused by the monkeypox virus and an increasing global incidence with a 2022 outbreak that has spread to Europe amid the COVID-19 pandemic. The new outbreak is associated with novel, previously undiscovered mutations a nd variants. Currently the US Food and Drug Administration (FDA) approved poxvirus treatment involves use of tecovirimat. However, there is limited pharmacopoeia otherwise, and limited research interest in monkeypox. In this study, virtual screening and molecular dynamics were employed to explore the potential repurposing of multiple drugs previously approved by the FDA or other jurisdictions for other applications. Several drugs are predicted to tightly bind to viral proteins which are crucial in viral replication, including molecules which show high potential for binding the monkeypox D13L capsid protein, whose inhibition has previously been demonstrated to suppress viral replication.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 96%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 96%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 95%
Similar papers in this journal
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 95%
- Structural analysis and ensemble docking revealed the binding modes of selected progesterone receptor modulators 95%
- Molecular Elucidation of Pancreatic Elastase Inhibition by Baicalein 95%
Similar papers in this journal
- Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cells 96%
- Single nucleotide polymorphism induces divergent dynamic patterns in CYP3A5: a microsecond scale biomolecular simulation of variants identified in Sub-Saharan African populations 95%
- Elucidation of Structural Mechanism of ATP Inhibition at the AAA1 Subunit of Cytoplasmic Dynein 1 Using a Chemical "Toolkit" 95%
Similar papers in this journal
- Role of Dengue in SARS-CoV-2 Evolution in Dengue Endemic Regions 94%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 94%
- Computationally Grafting an IgE Epitope onto a Scaffold: Implications for a Pan Anti-Allergy Vaccine Design 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.